See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Pope Francis
Vatican
Catholic Church
Social Media
Artificial Intelligence
Church
IPL
Donald Trump
NFL
Trade War
Tariffs
Published • loading... • Updated

Bavencio Maintains Bladder Cancer Benefit in Patients with Diabetes

Summary by curetoday.com
Bavencio improved survival in patients with bladder cancer, irrespective of diabetes status, according to an analysis of the JAVELIN Bladder 100 trial.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
curetoday.comcuretoday.com

Bavencio Maintains Bladder Cancer Benefit in Patients with Diabetes

Bavencio improved survival in patients with bladder cancer, irrespective of diabetes status, according to an analysis of the JAVELIN Bladder 100 trial.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

curetoday.com broke the news in on Sunday, April 20, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Diabetes

Diabetes

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal